Toll-like receptor 2 variants are associated with acute reactive arthritis

Arthritis and Rheumatism

Volumn 58, Issue 11, 2008, Pages 3436-3438

  Tsui, Florence W L ^a   Xi, Nancy ^a   Rohekar, Sherry ^b   Riarh, Reena ^c   Bilotta, Rose ^c   Hing, Wo Tsui ^a   Inman, Robert D ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SALMONELLA ENTERITIDIS; SALMONELLOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS, REACTIVE; DISEASE OUTBREAKS; FEMALE; GENETIC VARIATION; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS; TOLL-LIKE RECEPTOR 2;

EID: 55849142937     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.23967     Document Type: Article

References (16)

1. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors [review]. Semin Immunol 2007;19:3-10.
2. Moens L, Verhaegen J, Pierik M, Vermeire S, de Boeck K, Peetermans WE, et al. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect 2007;9:15-20.
3. Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol 2007;14:48-54.
4. Akashi-Takamura S, Miyake K. Toll-like receptors (TLRs) and immune disorders [review]. J Infect Chemother 2006;12:233-40.
5. Rohekar S, Tsui FW, Tsui HW, Xi N, Riarh R, Bilotta R, et al. Symptomatic acute reactive arthritis after an outbreak of Salmonella. J Rheumatol 2008;35:1599-602.
6. Roy MF, Lariviere L, Wilkinson R, Tam M, Stevenson MM, Malo D. Incremental expression of Tlr4 correlates with mouse resistance to Salmonella infection and fine regulation of relevant immune genes [published erratum appears in Genes Immun 2006;7:437]. Genes Immun 2006;7:372-83.
7. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure and signaling. J Immunol 2006;177:322-32.
8. Snelgrove T, Lim S, Greenwood C, Peddle L, Hamilton S, Inman R, et al. Association of Toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol 2007;34:368-70.
9. Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P. Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 2007;16:1225-32.
10. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398-401.
11. Woehrle T, Du W, Goetz A, Hsu HY, Joos TO, Weiss M, et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 2008;41:322-9.
12. Gautam JK, Ashish, Comeau LD, Krueger JK, Smith MF Jr. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling. J Biol Chem 2006;281:30132-42.
13. Ogus AC, Toldas B, Ozdemir T, Uguz A, Olcen S, Keser I, et al. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004;23:219-23.
14. Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. TLR-2 gene A753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 2005;83:535-41.
15. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, et al. Toll-like receptor-1, -2 and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006;12:1-8.
16. Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007;56:1536-42.